G Medical Innovations Holdings Ltd (GMVDF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 7, 2025, 8:00 PM EDT
GMVDF Revenue
In the year 2022, G Medical Innovations Holdings had annual revenue of $4.42M, down -10.91%. G Medical Innovations Holdings had revenue of $2.20M in the half year ending December 31, 2022, a decrease of -24.01%.
Revenue
4.42M
Revenue Growth
-10.91%
P/S Ratio
0.01
Revenue / Employee
52.62K
Employees
84
Market Cap
26.44K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 4.42M | -541.00K | -10.91% |
Dec 31, 2021 | 4.96M | 61.00K | 1.24% |
Dec 31, 2020 | 4.90M | -626.00K | -11.33% |
Dec 31, 2019 | 5.53M | 2.46M | 80.47% |
Dec 31, 2018 | 3.06M | 2.95M | 2,709.17% |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |